Topics

Gilead’s experimental Ebola drug being tested in patients infected with coronavirus

07:24 EST 3 Feb 2020 | Pharmafile

China and the US are testing Gilead’s remdesivir in patients with the coronavirus, in the hopes of developing an effective treatment for a disease that does not yet have a vaccine.

This new anti-viral drug had been created with an aim to treat Ebola and SARS. It is being studied by a medical team at the China-Japan Friendship Hospital in Beijing for efficacy in treating the coronavirus. It has been giving to a small number of patients with the disease.

read more

Original Article: Gilead’s experimental Ebola drug being tested in patients infected with coronavirus

NEXT ARTICLE

More From BioPortfolio on "Gilead’s experimental Ebola drug being tested in patients infected with coronavirus"

Quick Search

Relevant Topics

Vaccine
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one ...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Marburg and Ebola Virus Infections
Ebola virus and Marburg virus are related viruses that cause hemorrhagic fevers — illnesses marked by severe bleeding (hemorrhage), organ failure and, in many cases, death. Both viruses are native to Africa, where sporadic outbreaks have occurred f...